Covid Vaccine in 2021: Pfizer-BioNTech to Produce 2 Billion Doses

US-based pharma major Pfizer and a German pharmaceutical company BioNTech are gonna increase the manufacturing capacity to produce two billion doses of Covid-19 vaccine in this year, 2021.

Pfizer and BioNTech are to produce two billion doses of Covid-19 vaccine this year amid a surge in the global demand. Pfizer is a US-based pharma company and BioNTech is a German pharmaceutical company.

"In order to respond to an //increased global demand, we plan to manufacture two billion doses of our Covid-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50 percent," BioNTech said in a statement on Monday.

BioNTech CEO Says COVID-19 Virus Will Stay With Us For Next 10 Years
The deadly coronavirus is going to stay with us for the next decade at least, said BioNTech CEO Ugur Sahin.

‘According to Johns Hopkins University, the total number of global Covid-19 cases has topped 103.3 million, while the deaths have surged to more than 2.23 million.’

According to the pharmaceutical company, the implementation of three key initiatives is making good progress.

First, the modification of production processes at Pfizer's facility in Puurs, Belgium, has been successfully completed. It added that the original schedule of vaccine dose deliveries to the European Union is now back.

Second, BioNTech's manufacturing site in Marburg has received a manufacturing license and will be able to start production for validation by European Medicines Agency (EMA) in February in line with previously announced plans.

Pfizer-BioNTech Covid Vax Approved for Use by Singapore
Singapore on Monday followed a growing list of countries, including the US and the UK, in granting the use of the Pfizer-BioNTech vaccine to prevent Covid-19 in individuals aged 16 years and above.

Third, the company's European manufacturing network has continually expanded -- from three partners in December 2020 when it received the first authorisations to 13 currently (including the Marburg facility), it added.

The company is now in discussions with additional qualified partners on potential new agreements.

Coronavirus Vaccine is 90% Effective: Pfizer and BioNTech
US-based pharmaceutical major Pfizer and German biotech firm BioNTech announced that their COVID-19 vaccine candidate was found to be more than 90 percent effective in preventing coronavirus in the first interim analysis of data from a late-stage Phase 3 trial.

"Pfizer and BioNTech continue to work toward increased deliveries beginning the week of February 15, ensuring we will supply the full quantity of vaccine doses in the first quarter we contractually committed to and up to an additional 75 million doses to the European Union in the second quarter," the company said.

In December 2020, BioNTech CEO Ugur Sahin said that the deadly virus is going to stay with us for the next 10 years at least.

WHO Experts to Provide Guidelines on Moderna's COVID Vaccine
World Health Organization (WHO) panel of vaccine experts is set to issue recommendations on Moderna's COVID-19 vaccine on Tuesday.

The total number of global Covid-19 cases has topped 103.3 million, while the deaths have surged to more than 2.23 million, according to Johns Hopkins University.

Source-IANS